Clinical Trials Directory

Trials / Completed

CompletedNCT00448188

Bleeding Risk in CVCs

Thrombocytes and International Normalized Ratio Are no Predictors for Bleeding in Application of Central Veneous Catheters

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since many of the patients in an intensive care unit suffer from disorders of hemostasis, bleeding is a main concern applying central venous catheters. Even if there are some data indicating elevated international normalized ratio may not increase the risk of bleeding no clear cut-off has been defined so far. An INR \> 1.5 is generally considered to increase the risk of bleeding. Furthermore, many authors consider platelets below 50 x 109 /l as a contra-indication to CVC cannulation, since there are some data this may increase the risk of bleeding. Therefore platelet transfusion before venous puncture is suggested. In our clinical experience INR \> 1.5 and platelets \< 50 x 109 /l do not correlate with increased risk of bleeding. The aim of this study is to demonstrate, that coagulopathy, defined by INR and platelet count, is not decisive for bleeding.

Conditions

Interventions

TypeNameDescription
PROCEDUREcentral venous catheter application

Timeline

Start date
2005-11-01
Completion
2007-03-01
First posted
2007-03-16
Last updated
2013-01-28

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00448188. Inclusion in this directory is not an endorsement.